Reports

• Chandra K, Blackhouse G, McCurdy B, Bornstein M, Campbell K, Costa V, Franek J, Kaulback K, Levin L, Sehatzadeh S, Thabane M, Sikich N, Goeree R. Cost-effectiveness of interventions for chronic obstructive pulmonary disease using an Ontario policy model.   (forthcoming).
• Bowen JM, Snead OC, Hopkins RB, Elliott I, Burke N, Atkin J, Hebbard M, Brown L, Xie F, Tarride J-E, O’Reilly DJ, Goeree R. Diagnostic evaluation of infants, children and adolescents with epilepsy for surgery candidacy and the role of magnetoencephalography (MEG) [Report No. FEEAP-HTA013a-2011.REP]. Hamilton (ON): Programs for Assessment of Technology in Health, St. Joseph’s Healthcare Hamilton/McMaster University; 2011 pdf
• O'Reilly DJ, Blackhouse G, Paquette-Warren J, Fournie M, Goeree R, Harris SB.  Long-term cost-utility of a quality improvement collaborative focusing on patients with type 2 diabetes mellitus.  Report No.:  TEMMP-D034-2011-REP.  Prepared for the Partnerships in Health Project.  February 8, 2011 (21p.).
• Assasi N, Campbell K, Blackhouse G, Xie R, Gaebel K, Goeree R.  Ventilation during patient transport:  a review of clinical effectiveness and guidelines.  Ottawa:  Canadian Agency for Drugs and Technologies in Health; 2010.  pdf
• Bowen JM, Chow BJW, Freeman MR, Hopkins RB, Provost Y, Tarride J-E, Dennie C, Cohen EA, Marcuzzi D, Iwanochko R, Moody AR, Paul N, Parker JD, O’Reilly DJ, Xie F, Goeree R. Ontario Multidetector Computed Tomographic Coronary Angiography Study (OMCAS): An evaluation of diagnostic accuracy [Report No. FEEAP-HTA007-2010.REP]. Hamilton (ON): Programs for Assessment of Technology in Health, St. Joseph’s Healthcare Hamilton/McMaster University; 2010. pdf
• Assasi N, Blackhouse G, Xie F, Gaebel K, Robertson D, Hopkins R, Healey J, Roy D, Goeree R. Ablation procedures for rhythm control in patients with atrial fibrillation: clinical and cost-effectiveness analyses [Technology Report No. 128].  Ottawa: Canadian Agency for Drugs and Technologies in Health; 2010.  pdf
• Blackhouse G, Assasi N, Campbell K, Gaebel K, Xie F, Sutherland S, Goeree R.  Left atrial appendage occlusion:  cost-effectiveness in a Canadian setting.  Ottawa: Canadian Agency for Drugs and Technologies in Health; 2010.  pdf
• Gaebel K, Campbell K, Blackhouse G, Xie F, Assasi N, Goeree R.  Alpha1-proteinase inhibitor therapy for alpha1-antitrypsin deficiency: a review of the clinical evidence.  Ottawa: Canadian Agency for Drugs and Technologies in Health: 2010.  pdf
• Sutherland S, Gaebel K, Campbell K, Blackhouse G, Xie F, Assasi N, Doble B, Goeree R. Bluetooth®-enabled hearing technologies: A review of the clinical and cost-effectiveness. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2010. pdf 
• Gaebel K, Blackhouse G, Robertson D, Xie F, Assasi N, McIvor A, Hernandez P, Goeree R. Triple therapy for moderate-to-severe chronic obstructive pulmonary disease [Technology Report No. 127]. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2010. pdf

2. 1
3. 2
4. 3
5. Next page